Mr. Lars Rebien Sorensen
Chief Executive Office
Novo Nordisk A/S
Novo Allé
2880 Bagsvaerd
Copenhagen, Denmark

Dear Mr. Sorensen,

As a shareholder, I am distressed that you have been unable to increase the rate of return over 37%. It takes me three whole years to double my money.
Furthermore, I am afraid that I made a bad business decision as my $127.52 investment in your company may now be in danger.

I do not think it was wise to set up a non-profit medical research corporation to launder money to bribe doctors to test your off-label drug on wounded American soldiers in Iraq and Afghanistan, without their knowledge or consent, especially as the drug is more dangerous but not more effective than other drugs that were legally approved. It appears from newspaper reports that there were some deaths involved. Americans, even the pacifists among them, tend to react negatively when anyone harms their wounded volunteer soldiers.

You think that you succeeded, because as you planned, the wounded soldiers go back to the U.S.A. and take their drugs with him – your drug has now spread into military and civilian hospitals, at $10,000 per injection,

And you say that it was easier to pay the $25 million penalty than be taken to court. Sure, because a court cast would drag the whole sordid story into the light.

It is saddening to think of all the people involved to set up the phoney medical research foundation, to launder the bribes to doctors; and all the meetings and memos and e-mails over a period of years, and cultivating and seducing and bribing the doctors, and then actually getting your drug out to the soldiers in the war… hundreds of people were involved in this, at the highest levels of the company and the highest levels of society and the highest levels of medical science, and nobody said, “Ahhh, I am not so sure that illegally injecting wounded U.S. soldiers with an unproven, dangerous and mediocre drug, is really the best marketing approach, especially in the U.S.A. It is not a great idea to harm the U.S. Marines, Navy Seals, Army, etc. Those people take care of their own. They don’t like having their wounded killed by inferior drugs brought in by corrupting and bribing military personnel. There just might be a backlash. As a marketing method, it’s pretty risky. And then even beyond our market share, and our annual bonuses for cranking up the profits without even considering the rights of the patient, there is an ethical question here…”

Ethical question? Fire that guy immediately.

But actually, the ones who ask questions have long since been weeded out, when Pharma got rid of men of science, men like Dr. Merck who always said that the patient is the center of it all, and if Pharma does the right thing, the profits will follow – almost all the major Pharmas are now run by lawyers representing fast money – the management team will be booted out if they do not increase price share and get 40% rates of return.

I will sell my share if I can’t double my money faster than three years.
Could you not find something expensive to inject into widows and orphans? Your job is to make me get rich quick. If you can’t do it, the Board will bring in someone with less scruples to get the job done. Ethics are okay for nuns and choir boys. People like you and me have a lot of castles to maintain, and good servants are hide to find.

What will happen next is that the U.S. military doctors who accepted bribes will be court-martialled and imprisoned for a long time and discharged dishonourably and disgraced. And the Pharma execs will fly off to their castles in their private jets, and whatever fines they have to pay are simply added to the cost of the drugs.

It is part of the laws of Nature, Man and God that this type of contraption will collapse on itself all of a sudden some day. It is too twisted to stand up forever. It is a house built on sand, and it will one day rain and rain and rain. Noah was right: it’s time to build a boat.

Bob Dawson
Parkinson’s Underground
Temporarily in Nunavut
http://www.bnet.com/blog/drug-busine...tag=nl.rSINGLE

http://www.drugs.com/news/federal-ag...ing-24468.html